AGCO Corporation entered into an employment agreement with Indira Agarwal, effective August 1, 2026. The agreement outlines her role as Senior Vice Pr...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
News Corp has announced an equal access scheme buyback of Class A common stock, effective as of August 3, 2026. This is an update to a previous notifi...
Edible Garden signed a supplemental purchase agreement, extending its relationship with Meijer Distribution through 2027 to supply the Fresh From Meij...
Hess Midstream reported second quarter 2026 net income attributable to the company of $96.4 million, adjusted EBITDA of $313.7 million, and increased ...
Brookfield completed its acquisition of Oaktree, a premier credit manager, significantly expanding its credit platform and establishing the U.S. as it...
Lindblad Expeditions reported Q2 2026 revenue of $199.2 million, a 19% increase, while improving its net loss to $1.4 million. The company's adjusted ...
Rocket Pharmaceuticals reported that its RP-A501 gene therapy was well-tolerated with no significant safety concerns observed in three treated patient...
Institutional holdings report (13F-HR) filed by ZENITH SOLUTIONS, INC.....
Tyson Foods reported increased sales and adjusted operating income for Q3 2026, driven by strong demand in Chicken and Prepared Foods segments, despit...
Twist Bioscience reported record $118.4 million Q3 FY26 revenue, growing 23% sequentially for the 14th consecutive time. The company raised FY26 reven...
Cocrystal Pharma entered into a securities purchase agreement with OPKO Health, Inc. for the sale of common stock. The terms set a floor for the share...
Sally Beauty Holdings Q3 fiscal 2026 net sales rose 0.2% as GAAP diluted EPS increased 25%. The company repurchased $25 million in shares and narrowed...
BCB Bancorp reported a second-quarter net loss of $14.8 million due to a $19.0 million credit loss provision, dropping its efficiency ratio to 96.8%. ...
The company plans to submit its AXPAXLI NDA for wet AMD in Q4 2026 and reported a balance of $598.6M to support commercialization efforts....
SmartKem plans a reverse merger with Ferrox, following board approval, to combine operations under SMTK....
TG Therapeutics reported Q2 2026 total global revenue of approximately $240 million, exceeding its guidance. The company raised its full year financia...
Tonix Pharmaceuticals announced positive feedback for the design of an adaptive Phase 2 Lyme disease study of TNX-4800, with plans to begin the trial ...
Krystal Bio reported $119.2M in VYJUVEK revenue for Q2 2026, showcasing growing commercial traction. Maintaining a $1.1B cash balance, the company is ...
The company announced full enrollment in its BUOY-1 Phase 2b trial of GlyphAllo for MDD and shared financial highlights, advancing its pipeline of neu...
D-Wave Quantum announced a collaboration with Nasdaq Verafin to evaluate quantum-hybrid technology for improving predictive systems in financial crime...